drugset / Trial / NCT00608699

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

NCT00608699

Phase 1 Completed 24 enrolled GlaxoSmithKline
RandomizedSingle-groupSingle-blindDiagnostic

Summary

To test the ability of GSK256073 to block niacin-induced flushing when GSK256073 and niacin are co-administered as single doses to HVTs.

Timeline

Start
2007-12
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK256073A Unknown
Background Niacin Small molecule

Indications